REQUEST A DEMO
Total
USD $0.00
Search more companies

Mp Pharm sp. j. Kulon-Dorobek I S-Ka (Poland)

Main Activities: Department Stores
Full name: Mp Pharm sp. j. Kulon-Dorobek I S-Ka Profile Updated: August 30, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Mp Pharm sp. j. Kulon-Dorobek I S-Ka is an enterprise based in Poland. Its main office is in Swidnica. The company operates in the Department Stores sector. The enterprise was incorporated on January 10, 2017. The latest financial highlights indicate a net sales revenue drop of 9.23% in 2021. Its’ total assets recorded a growth of 2.65%. The net profit margin of Mp Pharm sp. j. Kulon-Dorobek I S-Ka increased by 3.21% in 2021.

Headquarters
Ul. Bartosza Glowackiego 28
Swidnica; Dolnoslaskie; Postal Code: 58-100

Contact Details: Purchase the Mp Pharm sp. j. Kulon-Dorobek I S-Ka report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mp Pharm sp. j. Kulon-Dorobek I S-Ka report to view the information.
Incorporation Date:
January 10, 2017
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Mp Pharm sp. j. Kulon-Dorobek I S-Ka report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-9.23%
Total operating revenue
-7.59%
Operating profit (EBIT)
97.96%
EBITDA
98.05%
Net Profit (Loss) for the Period
99.26%
Total assets
2.65%
Total equity
99.26%
Operating Profit Margin (ROS)
3.19%
Net Profit Margin
3.21%
Return on Equity (ROE)
0%
Debt to Equity Ratio
-114.06%
Quick Ratio
0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?